Skip to main content
SpringerLink
Log in

Significance of systemic inflammatory response syndrome after surgical treatment for thoracic esophageal cancer

  • Original article
  • Published:
The Japanese Journal of Thoracic and Cardiovascular Surgery Aims and scope Submit manuscript

Abstract

We studied the significance of Systemic Inflammatory Response Syndrome (SIRS) state after surgical treatment of thoracic esophageal cancer. From January 1991 to December 1995, 35 patients received thoracic esophageal cancer surgery. Thirty three patients (94.3%) were in the SIRS state after surgery and mean duration of SIRS was 3.4 days. Duration of SIRS was statistically longer in patients with pulmonary complications. Patients with hyperbilirubinemia (≧3.0 mg/dl) after surgery had longer duration of SIRS. Induction therapy did not affect the duration of SIRS. Collectively, duration of SIRS is an indication of complications, especially of pulmonary complications, after surgical treatment of thoracic esophageal cancer, and blood bililubin score after surgery correlates to duration of SIRS. These suggest that we must pay special attention to patients with long duration of SIRS or hyperbilirubinemia after thoracic esophageal surgery.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Reference

  1. Members of the American Colleage of Chest Physicians/Society of Critical Care Medicine Consensus Conference Comittee: Definition for sepsis and organ failure and guidlines for the use of innovative therapies in sepsis. Crit Care Med 20: 864–874, 1992

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Thoracic and Cardiovascular Surgery, Ishikawa Prefectural Central Hospital, Kanazawa, Japan

    Shun-ichi Watanabe M.D., Hideo Sato M.D., Kanae Tawaraya M.D., Makoto Tsubota M.D., Masamitsu Endo M.D. & Masahiro Seki M.D.

  2. Department of General and Gastrointestinal Surgery, Ishikawa Prefectural Central Hospital, Kanazawa, Japan

    Tetsuji Yamada M.D. & Masaaki Nakagawa M.D.

Authors
  1. Shun-ichi Watanabe M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hideo Sato M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Kanae Tawaraya M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Makoto Tsubota M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Masamitsu Endo M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Masahiro Seki M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Tetsuji Yamada M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Masaaki Nakagawa M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Watanabe, Si., Sato, H., Tawaraya, K. et al. Significance of systemic inflammatory response syndrome after surgical treatment for thoracic esophageal cancer. Jpn J Thorac Caridovasc Surg 46, 549–555 (1998). https://doi.org/10.1007/BF03250598

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03250598

Keywords

Search

Navigation